Blaj, S. and Piso, P. 2018. Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?. Current Issues in Pharmacy and Medical Sciences. 30, 4 (Jan. 2018), 207–210. DOI:https://doi.org/10.1515/cipms-2017-0040.